Literature DB >> 10407857

X-linked dilated cardiomyopathy and the dystrophin gene.

A Ferlini1, C Sewry, M A Melis, A Mateddu, F Muntoni.   

Abstract

X-linked dilated cardiomyopathy (XLDC) represents a well known genetic disease, allelic to Duchenne and Becker muscular dystrophies and caused by dystrophin gene mutations. XLDC is a rare disease and only few families have been fully characterised. In several of them, the dystrophin mutations show a different pattern of expression in cardiac compared to skeletal muscle. In the families with the most severe cardiac phenotype, the cardiac muscle is usually unable to produce dystrophin, due to a specific effect that the mutation(s) have on the gene transcription in this tissue. The skeletal muscle escapes the dystrophic changes by maintaining dystrophin synthesis via exon skipping or alternative splicing that the heart is not able to put in place. In this paper we have reviewed the families with X-linked dilated cardiomyopathy reported so far; in addition we provided novel transcription data on two families we previously described. The aim of this review is to attempt a genotype-phenotype correlation and speculate on common pathogenic mechanisms underlying this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10407857     DOI: 10.1016/s0960-8966(99)00015-2

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  29 in total

Review 1.  Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Authors:  Jarmila Machackova; Judit Barta; Naranjan S Dhalla
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

Review 2.  Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue.

Authors:  Thomas Kislinger; Anthony O Gramolini; David H MacLennan; Andrew Emili
Journal:  J Am Soc Mass Spectrom       Date:  2005-08       Impact factor: 3.109

Review 3.  Genetic testing for inherited cardiac disease.

Authors:  Arthur A M Wilde; Elijah R Behr
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

Review 4.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

5.  A novel cryptic exon identified in the 3' region of intron 2 of the human dystrophin gene.

Authors:  Van Khanh Tran; Zhujun Zhang; Mariko Yagi; Atsushi Nishiyama; Yasuaki Habara; Yasuhiro Takeshima; Masafumi Matsuo
Journal:  J Hum Genet       Date:  2005-08-30       Impact factor: 3.172

6.  Genetic inhibition of PKA phosphorylation of RyR2 prevents dystrophic cardiomyopathy.

Authors:  Satyam Sarma; Na Li; Ralph J van Oort; Corey Reynolds; Darlene G Skapura; Xander H T Wehrens
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-06       Impact factor: 11.205

Review 7.  Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.

Authors:  N Cohen; F Muntoni
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

8.  Gene expression profiling of the aging mouse cardiac myocytes.

Authors:  Natalya Bodyak; Peter M Kang; Makoto Hiromura; Indra Sulijoadikusumo; Nobuo Horikoshi; Konstantin Khrapko; Anny Usheva
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

9.  Differential stabilities of alternative exon-skipped rod motifs of dystrophin.

Authors:  Chris Ruszczak; Ahmed Mirza; Nick Menhart
Journal:  Biochim Biophys Acta       Date:  2009-03-12

10.  Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle.

Authors:  DeWayne Townsend; Soichiro Yasuda; Sheng Li; Jeffrey S Chamberlain; Joseph M Metzger
Journal:  Mol Ther       Date:  2008-04-15       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.